Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 59

Sort by

Sort Order Select

Journal Articles

Parametric Modeling of "Chemotherapy-Free" Regimens in CLL

Mitchell R. Smith, MD PhD, Robert Weiss, PhD

Blood (2018) 132 (Supplement 1): 5555.

https://doi.org/10.1182/blood-2018-99-119782

Published: 2018

Journal Articles

A Novel Role for Histone Deacetylase 10 (HDAC10) in the Regulation of PD-L1 Expression and Immune Tolerance Mediated By Antigen Presenting Cells (APCs)

Michael Wang, Bachelor of Science, Fengdong Cheng, MD, Jie Chen, PhD, Yixuan Li, PhD, Alejandro Villagra, PhD, Mitchell R. Smith, MD PhD, Edward Seto, PhD, Eduardo Martin Sotomayor, MD

Blood (2017) 130 (Supplement 1): 3561.

https://doi.org/10.1182/blood.V130.Suppl_1.3561.3561

Published: 2017

Journal Articles

Evaluating the Efficacy, Safety, and Dose Dependent Activities of Entospletinib in Patients with Chronic Lymphocytic Leukemia

Jeffrey P. Sharman, MD, Kathryn S. Kolibaba, MD, Jose Azar, MD, Rama Balaraman, MD, Roger M. Lyons, MD, Mitchell R. Smith, MD PhD, Esteban Abella-Dominicis, MD, Wei Ye, PhD, Wen Shi, MD PhD, Thomas Giever, DO, Andres Forero-Torres, MD

Blood (2017) 130 (Supplement 1): 832.

https://doi.org/10.1182/blood.V130.Suppl_1.832.832

Published: 2017

Journal Articles

Marked Re-Expansion of Chimeric Antigen Receptor (CAR) T Cells and Tumor Regression Following Nivolumab Treatment in a Patient Treated with Axicabtagene Ciloleucel (axi-cel; KTE-C19) for Refractory Diffuse Large B Cell Lymphoma (DLBCL)

Brian T. Hill, MD PhD, Zachary J. Roberts, MD PhD, John M. Rossi, MS, Mitchell R. Smith, MD PhD

Blood (2017) 130 (Supplement 1): 2825.

https://doi.org/10.1182/blood.V130.Suppl_1.2825.2825

Published: 2017

Journal Articles

The Role of Post- Treatment Imaging in Detection of Relapsed Disease in Classical Hodgkin Lymphoma: The Cleveland Clinic Experience

Nikolaos Papadantonakis, MD PhD, Basel Rouphail, MD MBA, Jia Xuefei, Robert M. Dean, MD, Brian T. Hill, MD PhD, Brad Pohlman, MD, Mitchell R. Smith, MD PhD, Deepa Jagadeesh, MD MPH

Blood (2015) 126 (23): 5006.

https://doi.org/10.1182/blood.V126.23.5006.5006

Published: 2015

Journal Articles

Long-Term Outcomes, Secondary Malignancies, and Stem Cell Collection Following Bendamustine in Patients with Previously Treated Indolent Non-Hodgkin Lymphoma

Blood (2015) 126 (23): 3961.

https://doi.org/10.1182/blood.V126.23.3961.3961

Published: 2015

Journal Articles

Response Adapted Induction Therapy for Multiple Myeloma

Jason Valent, MD, Christy Samaras, DO, Debbie Hastings, Beth M Faiman, PhD RN, MSN, CNP, AOCN, Kimberly Hamilton, CNP, Brian J. Bolwell, MD, Janice Reed, RN, Mary Ann Karam, RN, Chad Cummings, MBA, Katherine Tullio, MPH, MS, Mitchell R. Smith, MD PhD, Hien K. Liu, MD, Frederic J Reu

Blood (2015) 126 (23): 3327.

https://doi.org/10.1182/blood.V126.23.3327.3327

Published: 2015

Journal Articles

Standard Duration of Varicella Zoster Virus Prophylaxis May be Inadequate to Prevent Viral Reactivation in Patients with Chronic Lymphocytic Leukemia Treated with Front-Line Bendamustine Plus Rituximab

Joshua M. Allen, MD, Lisa A. Rybicki, MS, Paolo F. Caimi, MD, Deepa Jagadeesh, MD MPH, Robert M. Dean, MD, Brad Pohlman, MD, Mitchell R. Smith, MD PhD, Matt Kalaycio, MD, Brian T. Hill, MD PhD

Blood (2015) 126 (23): 4167.

https://doi.org/10.1182/blood.V126.23.4167.4167

Published: 2015

Journal Articles

A Phase I Study of Ixazomib in Combination with Panobinostat and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Frederic J. Reu, MD, Jason Valent, MD, Ehsan Malek, MD, Ronald M. Sobecks, MD, Beth M Faiman, PhD RN, MSN, CNP, AOCN, Kimberly Hamilton, CNP, Jamie Elberson, RN, Sherry Fada, Hien K. Liu, MD, Christy Samaras, DO, Mitchell R. Smith, MD PhD

Blood (2015) 126 (23): 4221.

https://doi.org/10.1182/blood.V126.23.4221.4221

Published: 2015

Journal Articles

Grade 3 Follicular Lymphoma: Outcomes in the Rituximab Era

Moaath Mustafa Ali, MD, Basel Rouphail, MD MBA, Robert M. Dean, MD, Brian T. Hill, MD PhD, Deepa Jagadeesh, MD MPH, Brad Pohlman, MD, Mitchell R. Smith, MD PhD

Blood (2015) 126 (23): 1520.

https://doi.org/10.1182/blood.V126.23.1520.1520

Published: 2015

Journal Articles

Initial Therapy for Mantle Cell Lymphoma with Abbreviated R-CHOP Followed By Y 90 -Ibritumomab Tiuxetan: Ten Year Follow-up of the Phase 2 ECOG-ACRIN Study E1499

Mitchell R. Smith, MD PhD, Hailun Li, PhD, Fangxin Hong, PhD, Leo I. Gordon, MD, Randy D. Gascoyne, Elisabeth Paietta, MD, Ranjana H Advani, MD, Andres Forrero-Torres, Sandra J Horning, MD, Brad S. Kahl, MD

Blood (2015) 126 (23): 2702.

https://doi.org/10.1182/blood.V126.23.2702.2702

Published: 2015

Journal Articles

Clinical Activity of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Patients with CLL Previously Treated with an Inhibitor of B-Cell Receptor Pathway Signaling

Jeff P. Sharman, MD, Andrei R. Shustov, MD, Mitchell R. Smith, MD PhD, Thomas E. Boyd, MD, Christopher Hagenstad, MD, Kathryn S. Kolibaba, MD, Steve Abella, MD, Jing He, Clarence Eng, MPH, Jing Hu, PhD, Anita Reddy, PhD, Siddhartha Mitra, MDPhD, Christopher A. Yasenchak, MD, Farrukh T. Awan, MD MS

Blood (2015) 126 (23): 1744.

https://doi.org/10.1182/blood.V126.23.1744.1744

Published: 2015

Journal Articles

Prognostic Value of Pre-Transplant PET Scan in Patients with Diffuse Large B-Cell (DLBCL) Lymphoma Undergoing Autologous Stem Cell Transplantation (ASCT)

Allison M Winter, MD, Lisa A. Rybicki, MS, Shetal Shah, MD, Deepa Jagadeesh, MD MPH, Aaron T. Gerds, MD MS, Betty K. Hamilton, MD, Hien Liu, MD, Robert M. Dean, MD, Ronald Sobecks, MD, Brad Pohlman, MD, Steven Andresen, DO, Mitchell R. Smith, MD PhD, Matt Kalaycio, MD, Brian J. Bolwell, MD, Navneet S. Majhail, MD MS, Brian T. Hill, MD PhD

Blood (2015) 126 (23): 5495.

https://doi.org/10.1182/blood.V126.23.5495.5495

Published: 2015

Journal Articles

Safety and Efficacy of Once Weekly Subcutaneous Bortezomib in Advanced Stage AL Amyloidosis

Naresh Bumma, MD, Frederic J. Reu, MD, Christy Samaras, DO, Hien K. Duong, MD, Mitchell R. Smith, MD PhD, Jason Valent, MD

Blood (2014) 124 (21): 4753.

https://doi.org/10.1182/blood.V124.21.4753.4753

Published: 2014

Journal Articles

Post Transplant Lymphoproliferative Disorders (PTLD) after Solid Organ Transplant: Cleveland Clinic Experience

Deepa Jagadeesh, MD MPH, Sharjeel Hooda, MD MS, Kathleen B Fenner, MSHS, Lisa Rybicki, MS, Robert M Dean, MD, Brad Pohlman, MD, Brian T. Hill, MD PhD, Mitchell R. Smith, MD PhD

Blood (2014) 124 (21): 3008.

https://doi.org/10.1182/blood.V124.21.3008.3008

Published: 2014

Journal Articles

Comparison of Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma (BCL-U) Patient Outcomes: Intensive Therapy May Not Benefit BCL-U

Naresh Bumma, MD, Lisa Rybicki, MS, Paolo Caimi, MD, Deepa Jagadeesh, MD MPH, Robert M Dean, MD, Brad Pohlman, MD, Mitchell R. Smith, MD PhD, Brian T. Hill, MD PhD

Blood (2014) 124 (21): 3065.

https://doi.org/10.1182/blood.V124.21.3065.3065

Published: 2014

Journal Articles

Natural Killer Cell Dysfunction in Chronic Lymphocytic Leukemia Is Associated with Loss of the Mature KIR3DL1 + Subset

Alexander W. MacFarlane, PhD, Mowafaq Jillab, MD, Mitchell R Smith, MD PhD, R. Katherine Alpaugh, PhD, Marion E. Cole, MD, Samuel Litwin, PhD, Michael M. Millenson, MD, Tahseen I. Al-Saleem, MD, Adam D. Cohen, MD, Kerry S. Campbell, PhD

Blood (2014) 124 (21): 3318.

https://doi.org/10.1182/blood.V124.21.3318.3318

Published: 2014

Journal Articles

Activity of ABT-199 and Acquired Resistance in Follicular Lymphoma Cells

Juraj Bodo, PhD, Xiaoxian Zhao, PhD, Mitchell R. Smith, MD PhD, Eric D. Hsi, MD

Blood (2014) 124 (21): 3635.

https://doi.org/10.1182/blood.V124.21.3635.3635

Published: 2014

Journal Articles

Low Blood Absolute CD4 Counts Is Associated with Inferior Progression Free Survival in Diffuse Large B-Cell Lymphoma Independent of Age and IPI

Tahseen I. Al-Saleem, MD, Essel Dulaimi, MD, Michael M. Millenson, MD, Mitchell R. Smith, MD PhD, Julia Judd, Tianyu Li, Hossein Borghaei, DO, MS

Blood (2014) 124 (21): 5420.

https://doi.org/10.1182/blood.V124.21.5420.5420

Published: 2014

Journal Articles

Bulky Disease Does Not Adversely Affect Overall Survival in Early Stage Hodgkin Lymphoma: Role of Interim PET and Possible Omission of Radiotherapy in Select Patients

Priyanka A Pophali, MD, Lisa A. Rybicki, MS, Kathleen B Fenner, MSHS, Deepa Jagadeesh, MD MPH, Robert M Dean, MD, Brad Pohlman, MD, Mitchell R. Smith, MD PhD, Brian T. Hill, MD PhD

Blood (2014) 124 (21): 4428.

https://doi.org/10.1182/blood.V124.21.4428.4428

Published: 2014

NARROW

Parametric Modeling of "Chemotherapy-Free" Regimens in CLL

A Novel Role for Histone Deacetylase 10 (HDAC10) in the Regulation of PD-L1 Expression and Immune Tolerance Mediated By Antigen Presenting Cells (APCs)

Evaluating the Efficacy, Safety, and Dose Dependent Activities of Entospletinib in Patients with Chronic Lymphocytic Leukemia

Marked Re-Expansion of Chimeric Antigen Receptor (CAR) T Cells and Tumor Regression Following Nivolumab Treatment in a Patient Treated with Axicabtagene Ciloleucel (axi-cel; KTE-C19) for Refractory Diffuse Large B Cell Lymphoma (DLBCL)

The Role of Post- Treatment Imaging in Detection of Relapsed Disease in Classical Hodgkin Lymphoma: The Cleveland Clinic Experience

Long-Term Outcomes, Secondary Malignancies, and Stem Cell Collection Following Bendamustine in Patients with Previously Treated Indolent Non-Hodgkin Lymphoma

Response Adapted Induction Therapy for Multiple Myeloma

Standard Duration of Varicella Zoster Virus Prophylaxis May be Inadequate to Prevent Viral Reactivation in Patients with Chronic Lymphocytic Leukemia Treated with Front-Line Bendamustine Plus Rituximab

A Phase I Study of Ixazomib in Combination with Panobinostat and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma

Grade 3 Follicular Lymphoma: Outcomes in the Rituximab Era

Initial Therapy for Mantle Cell Lymphoma with Abbreviated R-CHOP Followed By Y 90 -Ibritumomab Tiuxetan: Ten Year Follow-up of the Phase 2 ECOG-ACRIN Study E1499

Clinical Activity of Entospletinib (GS-9973), a Selective Syk Inhibitor, in Patients with CLL Previously Treated with an Inhibitor of B-Cell Receptor Pathway Signaling

Prognostic Value of Pre-Transplant PET Scan in Patients with Diffuse Large B-Cell (DLBCL) Lymphoma Undergoing Autologous Stem Cell Transplantation (ASCT)

Safety and Efficacy of Once Weekly Subcutaneous Bortezomib in Advanced Stage AL Amyloidosis

Post Transplant Lymphoproliferative Disorders (PTLD) after Solid Organ Transplant: Cleveland Clinic Experience

Comparison of Burkitt Lymphoma (BL) and B-Cell Lymphoma, Unclassifiable with Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma (BCL-U) Patient Outcomes: Intensive Therapy May Not Benefit BCL-U

Natural Killer Cell Dysfunction in Chronic Lymphocytic Leukemia Is Associated with Loss of the Mature KIR3DL1 + Subset

Activity of ABT-199 and Acquired Resistance in Follicular Lymphoma Cells

Low Blood Absolute CD4 Counts Is Associated with Inferior Progression Free Survival in Diffuse Large B-Cell Lymphoma Independent of Age and IPI

Bulky Disease Does Not Adversely Affect Overall Survival in Early Stage Hodgkin Lymphoma: Role of Interim PET and Possible Omission of Radiotherapy in Select Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only